Coronary Artery Disease Phenotype Detection in an Academic Hospital System Setting

Amy Joseph1, Charles Mullett1,2, Christa Lilly3

  • 1Department of Pediatrics, School of Medicine, West Virginia University, Morgantown, West Virginia, United States.

Insights

A new algorithm accurately identifies coronary artery disease (CAD) phenotypes in electronic health records (EHRs), aiding in the detection of undiagnosed familial hypercholesterolemia (FH). This tool enhances large-scale patient monitoring and identification of at-risk individuals.

Area of Science:

  • Cardiology
  • Medical Informatics
  • Genetics

Background:

  • Coronary artery disease (CAD) poses a significant health burden in the U.S., particularly in West Virginia.
  • Undiagnosed familial hypercholesterolemia (FH) is a key contributor to CAD.
  • Identifying a CAD phenotype is crucial for detecting FH families.

Purpose of the Study:

  • To develop and validate an algorithm for detecting CAD phenotypes using discrete data elements from electronic health records (EHRs).
  • To assess the algorithm's accuracy and sensitivity across diverse patient cohorts.

Main Methods:

  • Developed an algorithm (CAD Algorithm I) to search EHR data, including diagnosis codes (ICD-9/10) and procedure codes (CPT).
  • Applied the algorithm to two distinct patient cohorts (n=500 each).
  • Systematically reviewed EHRs to confirm CAD diagnoses, refined the algorithm (CAD Algorithm II), and re-evaluated its performance.

Main Results:

  • CAD Algorithm I demonstrated 89.6% accuracy and 94.6% sensitivity.
  • The revised CAD Algorithm II achieved 92.4% accuracy and 98.2% sensitivity in group 1, and 93% accuracy in group 2.
  • Specific diagnostic and procedural codes proved more effective than generic terms for phenotype detection.

Conclusions:

  • CAD Algorithm II accurately and sensitively detects CAD on a large scale across varied patient populations.
  • This algorithm can be utilized for patient registry monitoring within EHR systems.
  • It serves as a valuable tool for identifying individuals with potential FH.
Abstract

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
176
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
161
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
95
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
126
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
672
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
191